| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Experience |
RTS Baxter,1 Cali; RTS Baxter,2 Bogotá, Colombia.
Objective: To describe the basic demographic characteristics of a
population of patients (pts) with terminal chronic renal disease in peritoneal
dialysis (PD) in a network of renal dialysis centers in Colombia.
Methods: It is cross-sectional descriptive study of cohort
considering the basic demographic information of the total of 52 renal clinics
of network RTS in Colombia between December 2006 and February 2007.
Results: In early 2007, the dialysis RTS network took care of 3322
pts in PD; of which 2238 (67.37%) corresponded to CAPD and 1084 (32.63%) to
the APD program. The average of age of the population was of 51.9, years,
being 50.1 for APD and 52.7 for CAPD. The causes of ERC for the population
were diabetes (31.2%), HTA (27.8%), glomerulonephritis (9.2%), other causes
(27.8%). The medium functionality of the pts in agreement with the scale of
Karnofsky was of 90; and the medium one of the comorbidity measured with the
scale of Charlson was of 2. The nutritional diagnosis based on the
classification of the dietician was: undernourished 4.2%, in risk of
undernourishment 8.2%, normal 54.2%, overweight 24.8%, and obesity 8.6%. The
malnutrition and inflammation score shows 78.6% from 0 to 10; 6.2% from 11 to
20; to greater 0.1% of 20, and without data 15.1%. Serum albumin shows the
following distribution:
3, 14.9%; from 3 to 3.4, 23.4%; from 3.5 to 3.9,
29.1%; >3.9, 22.4%; and without data, 10.1%. The tendencies of the therapy
show that in CAPD the pts in average receive 3.6 spare parts to the day with
the following mixture: Dianeal® of 1.5% of 2000 mL, 37.1%; Dianeal® of
2.5% of 2000 mL, 34.8%; Dianeal® of 4.25% of 2000 mL, 10.0%; Dianeal®
of 1.5% of 2500 mL, 9.1%; Dianeal® of 2.5% of 2500 mL, 6.8%; Dianeal®
of 4.25% of 2500 mL, 2.2%. In APD the pts in average receive 10.6 L of
Dianeal® to the day. Conclusions: This is the first time we
present the characteristics of our PD population, include adequacy,
nutritional, comorbidities, and functional data, as a base to compare with
other registries around the word. The data show the good quality of therapy we
deliver to our pts and help to understand other clinical outputs.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
 |
